Dupixent® / Sanofi Genzyme Head on Incredible Success of "Once-in-a-Career" Product
Sanofi’s inflammation drug Dupixent® is driving a substantial percentage of the firm’s sales in 2020,…
Dina Spencer |
Editor
Dina Spencer is Community Manager & Digital Editor at PharmaBoardroom. She lives in Madrid and is interested in all things international.
Articles: Dina Spencer
Sanofi / Thomas Triomphe Appointed Executive Vice President of Vaccines Unit
With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe…
Medtech / Strategies in Saudi Arabia
Saudi Arabia is seeing an increased demand for more innovative medical devices and a greater awareness of the…
COVID-19 / Cipla to Begin Manufacturing Remdesivir in South Africa
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a…
Roche / Back on Top of The Global Biopharma Rankings
Swiss giant Roche tops Pharmaceutical Executive’s 2020 list of the world’s biggest pharma companies, up…
China / Boehringer Ingelheim Creates New External Innovation Hub
With its brand new hub in Shanghai dedicated to research, business development and venture funding, German pharma…
COVID-19 / Top Tech Talent Making the Move to Pharma?
A new report by Novartis looks at how leading talent in the technology industry is increasingly looking to bring…
Clinical Trials / Chinese Sinovac Testing COVID-19 Vaccine in Brazil
In the race to develop the world’s first COVID-19 vaccine, Brazil – now one of the world’s…
Mid-Cap Strategies / LFB USA CEO Optimistic on Hemophilia Launches Amid COVID Crisis
French firm LFB is targeting the lucrative US market with its hemophilia products and recently received two FDA…
India / Six Companies at the Forefront of COVID-19 Vaccine Development
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
COVID-19 / The Wellcome Trust's Jeremy Farrar Speaks Out Against Vaccine Nationalism
Jeremy Farrar, director of the Wellcome Trust, spoke to Financial Times correspondent Vanessa Kortekaas on 25 June…
Sanofi / USD 679 Million Investment in French Vaccine Manufacturing
French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679…